Centenial Surgical Suture Share Price
Sector: Medical Equipment & Supplies
147.10 -1.55 (-1.04%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
142.10
Today’s High
148.60
52 Week Low
82.15
52 Week High
169.50
Key Metrics
- Market Cap (In Cr) 53.66
- Beta 0.66
- Div. Yield (%) 0
- P/B 1.74
- TTM P/E -
- Sector P/E 40.98
- D/E 0.01
- Open Price 148.6
- Prev Close 148.65
Centenial Surgical Suture Analysis
Price Analysis
-
1 Week1.45%
-
3 Months33.73%
-
6 Month7.1%
-
YTD6.59%
-
1 Year30.18%
Risk Meter
- 90% Low risk
- 90% Moderate risk
- 90% Balanced Risk
- 90% High risk
- 90% Extreme risk
Centenial Surgical Suture Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 53.52
- Selling/ General/ Admin Expenses Total
- 11.86
- Depreciation/ Amortization
- 4.25
- Other Operating Expenses Total
- 18.05
- Total Operating Expense
- 51.39
- Operating Income
- 2.13
- Net Income Before Taxes
- -1.62
- Net Income
- -1.46
- Diluted Normalized EPS
- -4.01
- Period
- 2025
- Total Assets
- 84.58
- Total Liabilities
- 53.83
- Total Equity
- 30.75
- Tangible Book Valueper Share Common Eq
- 84.29
- Period
- 2025
- Cashfrom Operating Activities
- 17.07
- Cashfrom Investing Activities
- -11.61
- Cashfrom Financing Activities
- -5.93
- Net Changein Cash
- -0.47
- Period
- 2024
- Total Revenue
- 51.19
- Selling/ General/ Admin Expenses Total
- 11.33
- Depreciation/ Amortization
- 1.39
- Other Operating Expenses Total
- 17.67
- Total Operating Expense
- 47.45
- Operating Income
- 3.74
- Net Income Before Taxes
- 1.27
- Net Income
- 1.13
- Diluted Normalized EPS
- 3.11
- Period
- 2024
- Total Assets
- 79.15
- Total Liabilities
- 46.93
- Total Equity
- 32.22
- Tangible Book Valueper Share Common Eq
- 88.3
- Period
- 2024
- Cashfrom Operating Activities
- 6.21
- Cashfrom Investing Activities
- -7.92
- Cashfrom Financing Activities
- 2.06
- Net Changein Cash
- 0.35
- Period
- 2023
- Total Revenue
- 52.66
- Selling/ General/ Admin Expenses Total
- 11.19
- Depreciation/ Amortization
- 1.3
- Other Operating Expenses Total
- 16.97
- Total Operating Expense
- 49.53
- Operating Income
- 3.13
- Net Income Before Taxes
- 1.46
- Net Income
- 0.89
- Diluted Normalized EPS
- 2.43
- Period
- 2023
- Total Assets
- 66.4
- Total Liabilities
- 35.32
- Total Equity
- 31.08
- Tangible Book Valueper Share Common Eq
- 85.19
- Period
- 2023
- Cashfrom Operating Activities
- 1.3
- Cashfrom Investing Activities
- -0.18
- Cashfrom Financing Activities
- -1.05
- Net Changein Cash
- 0.07
- Period
- 2022
- Total Revenue
- 44.43
- Selling/ General/ Admin Expenses Total
- 10.77
- Depreciation/ Amortization
- 1.53
- Other Operating Expenses Total
- 9.51
- Total Operating Expense
- 41.46
- Operating Income
- 2.97
- Net Income Before Taxes
- 1.07
- Net Income
- 0.63
- Diluted Normalized EPS
- 1.72
- Period
- 2022
- Total Assets
- 61.34
- Total Liabilities
- 31.14
- Total Equity
- 30.2
- Tangible Book Valueper Share Common Eq
- 82.76
- Period
- 2022
- Cashfrom Operating Activities
- 4.75
- Cashfrom Investing Activities
- -0.17
- Cashfrom Financing Activities
- -4.87
- Net Changein Cash
- -0.28
- Period
- 2021
- Total Revenue
- 36.93
- Selling/ General/ Admin Expenses Total
- 9.98
- Depreciation/ Amortization
- 1.55
- Other Operating Expenses Total
- 11.49
- Total Operating Expense
- 33.39
- Operating Income
- 3.55
- Net Income Before Taxes
- 1.53
- Net Income
- 0.96
- Diluted Normalized EPS
- 2.64
- Period
- 2021
- Total Assets
- 70.05
- Total Liabilities
- 40.47
- Total Equity
- 29.57
- Tangible Book Valueper Share Common Eq
- 81.04
- Period
- 2021
- Cashfrom Operating Activities
- -0.05
- Cashfrom Investing Activities
- -0.89
- Cashfrom Financing Activities
- 0.75
- Net Changein Cash
- -0.18
- Period
- 2020
- Total Revenue
- 55.61
- Selling/ General/ Admin Expenses Total
- 10.67
- Depreciation/ Amortization
- 1.55
- Other Operating Expenses Total
- 14.76
- Total Operating Expense
- 51.28
- Operating Income
- 4.34
- Net Income Before Taxes
- 2.16
- Net Income
- 1.3
- Diluted Normalized EPS
- 3.55
- Period
- 2020
- Total Assets
- 68.82
- Total Liabilities
- 40.21
- Total Equity
- 28.61
- Tangible Book Valueper Share Common Eq
- 78.39
- Period
- 2020
- Cashfrom Operating Activities
- 2.08
- Cashfrom Investing Activities
- -1.31
- Cashfrom Financing Activities
- -0.37
- Net Changein Cash
- 0.4
- Period
- 2019
- Total Revenue
- 56.05
- Selling/ General/ Admin Expenses Total
- 9.47
- Depreciation/ Amortization
- 0.69
- Other Operating Expenses Total
- 16.27
- Total Operating Expense
- 51.47
- Operating Income
- 4.59
- Net Income Before Taxes
- 2.84
- Net Income
- 2.02
- Diluted Normalized EPS
- 5.53
- Period
- 2019
- Total Assets
- 56.76
- Total Liabilities
- 28.71
- Total Equity
- 28.06
- Tangible Book Valueper Share Common Eq
- 76.86
- Period
- 2019
- Cashfrom Operating Activities
- 1.55
- Cashfrom Investing Activities
- -1.02
- Cashfrom Financing Activities
- -1.27
- Net Changein Cash
- -0.75
- Period
- 2025-03-31
- Total Revenue
- 13.31
- Selling/ General/ Admin Expenses Total
- 3.05
- Depreciation/ Amortization
- 1.26
- Other Operating Expenses Total
- 4.6
- Total Operating Expense
- 12.45
- Operating Income
- 0.85
- Net Income Before Taxes
- -1.34
- Net Income
- -1.18
- Diluted Normalized EPS
- -3.24
- Period
- 2025-03-31
- Total Assets
- 84.58
- Total Liabilities
- 53.83
- Total Equity
- 30.75
- Tangible Book Valueper Share Common Eq
- 84.29
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 17.07
- Cashfrom Investing Activities
- -11.61
- Cashfrom Financing Activities
- -5.93
- Net Changein Cash
- -0.47
- Period
- 2024-12-31
- Total Revenue
- 12.2
- Selling/ General/ Admin Expenses Total
- 3.19
- Depreciation/ Amortization
- 1.11
- Other Operating Expenses Total
- 5.01
- Total Operating Expense
- 12.55
- Operating Income
- -0.35
- Net Income Before Taxes
- -0.85
- Net Income
- -0.85
- Diluted Normalized EPS
- -2.3
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 14.27
- Selling/ General/ Admin Expenses Total
- 2.8
- Depreciation/ Amortization
- 1.09
- Other Operating Expenses Total
- 4.07
- Total Operating Expense
- 13.58
- Operating Income
- 0.69
- Net Income Before Taxes
- 0.17
- Net Income
- 0.13
- Diluted Normalized EPS
- 0.35
- Period
- 2024-09-30
- Total Assets
- 87.07
- Total Liabilities
- 54.43
- Total Equity
- 32.64
- Tangible Book Valueper Share Common Eq
- 89.46
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 11.71
- Cashfrom Investing Activities
- -10.18
- Cashfrom Financing Activities
- -1.06
- Net Changein Cash
- 0.47
- Period
- 2024-06-30
- Total Revenue
- 13.74
- Selling/ General/ Admin Expenses Total
- 2.82
- Depreciation/ Amortization
- 0.79
- Other Operating Expenses Total
- 4.36
- Total Operating Expense
- 12.81
- Operating Income
- 0.93
- Net Income Before Taxes
- 0.4
- Net Income
- 0.3
- Diluted Normalized EPS
- 0.82
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 12.05
- Selling/ General/ Admin Expenses Total
- 3.18
- Depreciation/ Amortization
- 0.44
- Other Operating Expenses Total
- 3.87
- Total Operating Expense
- 10.95
- Operating Income
- 1.1
- Net Income Before Taxes
- 0.15
- Net Income
- 0.29
- Diluted Normalized EPS
- 0.81
- Period
- 2024-03-31
- Total Assets
- 79.15
- Total Liabilities
- 46.93
- Total Equity
- 32.22
- Tangible Book Valueper Share Common Eq
- 88.3
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.21
- Cashfrom Investing Activities
- -7.92
- Cashfrom Financing Activities
- 2.06
- Net Changein Cash
- 0.35
- Period
- 2023-12-31
- Total Revenue
- 12.38
- Selling/ General/ Admin Expenses Total
- 2.62
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 4.66
- Total Operating Expense
- 11.46
- Operating Income
- 0.92
- Net Income Before Taxes
- 0.41
- Net Income
- 0.31
- Diluted Normalized EPS
- 0.84
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Centenial Surgical Suture Technical
Moving Average
SMA
- 5 Day146.69
- 10 Day143.86
- 20 Day141.83
- 50 Day131.7
- 100 Day124.11
- 300 Day128.75
Centenial Surgical Suture Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Maestros Electrncs & Telecom Sys
- 140.65
- -2.55
- -1.78
- 262.15
- 113.4
- 77.67
- Alan Scott Industries
- 104
- 0.13
- 0.13
- 186.29
- 47.02
- 57.13
- Centenial Surgical Suture
- 147.1
- -1.55
- -1.04
- 169.5
- 82.15
- 53.66
- Gkb Ophthalmics
- 74.97
- -1.13
- -1.48
- 131.75
- 59
- 37.84
- Shree Pacetronix
- 74.4
- 0.39
- 0.53
- 245
- 61.11
- 26.46
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Maestros Electrncs & Telecom Sys
- 18.04
- 2.26
- 15.24
- 13.13
- Alan Scott Industries
- -
- 29
- -72.98
- -15.92
- Centenial Surgical Suture
- -
- 1.76
- 1.4
- 0.9
- Gkb Ophthalmics
- -
- 0.74
- -3.18
- -2.4
- Shree Pacetronix
- 35.58
- 1.93
- 18.46
- 10.81
Centenial Surgical Suture Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results
- 14-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results & A.G.M.
- 28-May-24
- Audited Results
- 29-Apr-24
- Others
- 14-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 12-Aug-23
- Quarterly Results & A.G.M.
- 27-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 27-Sept-24
- 21-Aug-24
- AGM
- 21-Sept-23
- 14-Aug-23
- AGM
- 31-Mar-22
- 04-Mar-22
- EGM
- 28-Sept-21
- 10-Aug-21
- AGM



